Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population

May 1, 2002
Daniel A. Ollendorf, MPH

Anna N. Peterson, BA

Joseph Doyle, RPh, MBA

Daniel M. Huse, MA

Supplements and Featured Publications, Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care, Volume 8, Issue 7 Suppl